Webinar series: COVID-19 and Intensive Care Medicine, 2 June 2020 at 17:00 CET

In the context of COVID-19 pandemic and launching of the ‘COVID-19 Clinical Management Support System’, DG SANTE is organising a series of webinars to support clinicians and other healthcare professionals at the frontline who treat patients with COVID-19.

The next webinar will be held by Prof. Maurizio Cecconi, President Elect of the European Society of Intensive Care Medicine and Head of Department Anaesthesia and Intensive Care Units, Humanitas Research Hospital, Lombardy in Italy, and by Prof. Jozef Kesecioglu, President of the European Society of Intensive Care Medicine, expert on ethics and intensive care, Head of Intensive Care Centre of the University Medical Centre of Utrecht in The Netherlands. Attendees will then be able to ask questions to the speakers. The webinar will be recorded and available for off line vision afterwards.

To join the webinar, click here

Programme:

Agenda:
17.00 – 17.05 

 

17.05 – 17.25

 

 

 

 

17.25 – 17.45

 

 

 

 

17.45 – 18.00

  • Welcome DG SANTE, European Commission

 

 

  • Surge ICU response and clinical aspects and management Prof. Maurizio Cecconi – President Elect of the European Society of Intensive Care Medicine and Head of Department Anaesthesia and Intensive Care Units, Humanitas Research Hospital, Lombardy, Italy

 

  • Ethics and family involvement during a pandemic.

Prof. Jozef Kesecioglu – President of the European Society of Intensive Care Medicine; Expert on ethics and intensive care, Head of Intensive Care Centre of the University Medical Centre of Utrecht, Netherlands

 

  • Q&A

 

This entry was posted in General.

Recorded Webinar: COVID-19 & Endocrine conditions with increased risk – Endo-ERN

On May 12th 2020, a successful Endo-ERN webinar about COVID-19 & Endocrine conditions with increased risk was organized. The webinar was chaired by coordinator of Endo-ERN Prof. Alberto Pereira, Prof. Eelco de Koning, both from Leiden University Medical Center in the Netherlands and by ProfWiebke Arlt from University of Birmingham in the UK.

The recording of this webinar and presentations are published on the website of the European Commission. View the recording and presentations here.

For an overview of all previously organized & upcoming scheduled Endo-ERN webinars, click here.

This entry was posted in General.

ESE and Endo-ERN launch an initiative to collect data on patients with rare endocrine conditions and COVID-19

The ESE Rare Disease Committee, alongside Endo-ERN, have engaged in an initiative to collect data concerning specific groups of patients with rare endocrine conditions, who are also affected by COVID-19. We believe this is a global unmet need and requires swift, concerted and coordinated action.

The European Registries for Rare Endocrine Conditions (EuRRECa) project, supported by both Endo-ERN and ESE, has developed an e-reporting tool (e-REC) which has been fully operational for over a year within a robust governance and ethical framework and which does not require individual patient consent. The platform is now open to all centres across the world to report a new confirmed or suspected case of COVID-19 in a patient with an existing endocrine or metabolic bone condition.

We would like to encourage you to join us in this important initiative by registering on the e-REC platform and begin submitting data. If you would like to use the e-REC platform to report a new COVID-19 infection in a patient with an existing condition, please visit the e-REC platform and create an account.

If you are already an active user of e-REC, then, after login, you will need to revise your reporting set up.

You can find out more about the functionality of e-REC in this recent report. If you need any assistance, please email the EuRRECa team at info@eurreca.net.

This entry was posted in General.

ECRD 2020 Online 14-15 May

In the context of the current COVID-19 pandemic, the upcoming European Conference on Rare Diseases & Orphan Products (ECRD) will take place ONLINE on 14-15 May.

The ECRD is recognised globally as the largest, patient-led rare disease event in which collaborative dialogue, learning and conversation takes place, forming the groundwork to shape future rare disease policies.

The ECRD 2020 theme “The rare disease patient journey in 2030” recognises that the next decade holds great potential for improvement and that while we cannot predict the future, we all have a role in preparing for it. See the full ECRD programme built around the six parallel themes.

Register via this link. Deadline for registration is May 1st.

This entry was posted in General.

New Endo-ERN manuscript accepted for publication in European Journal of Endocrinology

We are proud to announce that the manuscript from Work Package 5 “Diagnostics & laboratory analysis” in collaboration with EU COST action, entitled “Peptide Hormone Analysis in Diagnosis and Treatment of Differences of Sex Development: Joint Position Paper of EU COST Action “DSDnet” and European Reference Network on Rare Endocrine Conditions” has been accepted for publication in European Journal of Endocrinology.

To view the publication, click here.

This entry was posted in General.

LUMC is actively involved in the international approach to rare diseases

How can we help patients with a rare disease in the best possible way? On Tuesday, February 18, the European strategy on rare diseases was discussed during the Rare Disease Day Policy Event with members of the European Parliament in Brussels. The Leiden University Medical Center (LUMC) was represented by. LUMC professor prof. Alberto Pereira as invited speaker, and as coordinator of the European reference network on rare endocrine conditions (Endo-ERN) sharing his experiences and vision for the future.

 

A person is considered having a rare disease if his or her condition affects less than 1 in 2,000 people, which means that about 30 million people livewith a rare condition in the European Union. It is estimated that around 6,000 rare diseases occur in Europe. Because these diseases require specialized and often complex treatment, patients often have difficulty acquiring  the correct diagnosis and appropriate treatment and care.

To provide patients access to the best care, it is important that health care providers (HCPs) from all over Europe actively exchange the required knowledge with each other. The ERN Hospital Managers network plays an important role in facilitating these European Reference Networks (ERNs). By bringing together specialists from across Europe, patients can be helped much faster and better in the future. Willy Spaan, chairman of the Board of Directors of LUMC, is the present chairman of this active network of European directors of academic medical centers and hospitals.

 

Rare Disease Day Policy Event

At the Rare Disease Day Policy Event stakeholders discuss what is needed in Europe to better respond to the needs of patients with a rare disease. Various leading healthcare professionals, policy makers and patients discussed the access to (orphan) medicines, holistic and patient-oriented care, research into patient-relevant outcome measures, and the effectiveness and added value of cross-border healthcare.

The LUMC strategically focuses on value-based healthcare, with the patient’s perspective playing a major role in shaping care. Several care pathways for patients with a many rare conditions have already been developed.

At LUMC, doctors and researchers are already dealing with 125 different rare diseases in 40 centers of expertise. The knowledge and experiences are discussed in Brussels. Among other things, Pereira explained the importance of joint research funding for ERNs, a coordinated access to data and services, capacity building, and the need fora rapid translation of research and therapy development.

 

International collaboration 

To further improve care for patients with a rare disease, health care professionals, researchers and patient representatives at LUMC have been exchanging specialist knowledge with other colleagues in the field through participation in 8 ERNs since 2017.. The LUMC is the coordinating center in Europe of the ERN on Rare Endocrine Conditions (Endo-ERN). By using novel ICT technology developed by the European Commission, the Clinical Patient Management System (CPMS), virtual consultation by a panel of Multidisciplinary experts enables patients with rare diseases from other European countries to obtain the required expertise without having to travel to the LUMC.

The LUMC is also a member of the International Rare Diseases Research Consortium (IRDiRC). This consortium is working on one clear mission: to provide all people with rare diseases with a precise diagnosis, the best care and therapy within one year after medical assistance.

This entry was posted in General.

EJPRD – ERN internal training and support program calls

EJP-RD has opened funding calls for training programs based on two main components: research mobility fellowship and research training workshops.

The aim of these programs is to fill the gap in the available education on rare diseases research by creating and implementing a comprehensive and cohesive program of education and empowerment for different target groups or stakeholders such as researches and young clinicians.

Submission for the fellowship is possible until 16th of March 2020. For the research training workshops, the deadline for submission is 2nd of March.

For more information, visit the website.

This entry was posted in General.